Page last updated: 2024-11-07

methylprednisolone acetate and Lupus Erythematosus, Systemic

methylprednisolone acetate has been researched along with Lupus Erythematosus, Systemic in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HARNECKER, J1
JALIL, J1

Other Studies

1 other study available for methylprednisolone acetate and Lupus Erythematosus, Systemic

ArticleYear
[A PROLONGED-ACTION CORTICOSTEROID. DEPO-MEDROL IN THE TREATMENT OF 25 CASES OF LUPUS ERYTHEMATOSUS DISSEMINATUS].
    Revista medica de Chile, 1964, Volume: 92

    Topics: Adrenal Cortex Hormones; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Methylprednisolo

1964